Pfizer vaccine trial success signals breakthrough in pandemic battle

Mitchell Daily Republic

Nov 10, 2020

If granted, the companies estimate they can roll out up to 50 million doses this year, enough to protect 25 million people, and then produce up to 1.3 billion doses in 2021.